Le Lézard
Classified in: Health, Science and technology, Business
Subject: ECO

Emergence of New Care Models to Drive the APAC EMR and EHR Market towards US$3.62 Billion by 2023, finds Frost & Sullivan


Vendors need to transform their business models and enhance product capabilities to increase revenue

SINGAPORE, Sept. 4, 2018 /PRNewswire/ -- Electronic Medical Record (EMR) and Electronic Health Record (EHR) technologies are making significant impacts on the way healthcare systems improve their capacity to better serve patients across Asia Pacific (APAC). By enhancing product capabilities and innovating new models, EMR/EHR vendors will be able to stay relevant as APAC healthcare industry undergoes disruptive transformation. Vendors who understand the emerging challenges and evolving market needs and take strategic actions will be best positioned for future success.

"The healthcare industry in APAC has started to emphasize more on population health management, proactive and predictive medicine, and evidence-based care. The need to integrate clinically significant patient information from all sources, clinical information systems, non-clinical information systems, and external sources with EMRs to create this comprehensive data warehouse is growing significantly," said Shalani Andria, Industry Analyst Transformational Health.

"To meet this growing demand and achieve a competitive edge, EMR and EHR solution providers need to provide affordable, highly scalable and interoperable solutions that are also customized for local workflows," she added.

Frost & Sullivan's recent analysis, Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023, focuses on the important trends, growth drivers and restraints, and top growth opportunities in the market through 2023.

For further information on this analysis, please visit: http://frost.ly/2qi

A few of the top growth opportunities examined in this analysis include:

"EMR vendors are evolving from being just EMR solution providers to being providers of completely integrated systems. Their robust EMR solutions - gather data from multiple sources, such as telehealth platforms, non-clinical solutions, genomics, and pharmacy IT, normalize data in different formats, and make it available for other applications such as analytical tools," said Andria.

"These solutions provide more functionality to developed nations that are moving from simply documenting medical records in electronic format to leveraging the data for cost-effective and high-quality healthcare services," she explained.

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023 is part of Frost & Sullivan's global Transformational Health Growth Partnership Service program.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023
PA17-48

Contact:

Melissa Tan
Corporate Communications ? Asia Pacific
P: +65 6890 0926
F: +65 6890 0999
E: [email protected]

http://ww2.frost.com

 

SOURCE Frost & Sullivan


These press releases may also interest you

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...



News published on and distributed by: